(2018). Amitriptyline inhibits the MAPK/ERK and CREB pathways and proinflammatory cytokines through .. Acute and Critical Care.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Amitriptyline Inhibits the MAPK/ERK and CREB Pathways and Proinflammatory Cytokines Through .."
Acute and Critical Care 2018.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Amitriptyline Inhibits the MAPK/ERK and CREB Pathways and Proinflammatory Cytokines Through .."
Acute and Critical Care, 2018.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.